Lambrinoudaki, I., Tsouvalas, E., Vakaki, M., Kaparos, G., Stamatelopoulos, K., Augoulea, A., . . . Karavanaki, K. Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor-κB Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus. Wiley.
Chicago Style (17th ed.) CitationLambrinoudaki, Irene, et al. Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor-κB Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus. Wiley.
MLA (9th ed.) CitationLambrinoudaki, Irene, et al. Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor-κB Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus. Wiley.
Warning: These citations may not always be 100% accurate.